Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Cell Biochem ; : e30632, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-39014931

RÉSUMÉ

Bronchopulmonary dysplasia (BPD) is a serious disease that occurs in premature and low-birth-weight infants. In recent years, the incidence of BPD has not decreased, and there is no effective treatment for it. Oridonin (Ori) is a traditional Chinese medicine with a wide range of biological activities, especially pharmacological and anti-inflammatory. It is well known that inflammation plays a key role in BPD. However, the therapeutic effect of Ori on BPD has not been studied. Therefore, in the present study, we will observe the anti-inflammatory activity of Ori in an experimental animal model of BPD. Here, we showed that Ori could significantly decrease hyperoxia-induced alveolar injury, inhibit neutrophil recruitment, myeloperoxidase concentrations, and release inflammatory factors in BPD neonatal rats. Taken together, the experimental results suggested that Ori can significantly improve BPD in neonatal rats by inhibiting inflammatory response.

2.
World J Clin Cases ; 9(19): 5037-5045, 2021 Jul 06.
Article de Anglais | MEDLINE | ID: mdl-34307554

RÉSUMÉ

BACKGROUND: Endometrial lesions include endometrial cancer and inferior fibroids. Among them, endometrial cancer as a malignant tumor seriously endangers the life and health of patients. Ultrasonography is an important means of diagnosing female reproductive system diseases, and it is of critical value for the early diagnosis of endometrial cancer. However, different ultrasound inspection programs have achieved different results. It is of great significance to choose a suitable inspection program. AIM: To explore the diagnostic efficacy of different ultrasonic examination methods in clinical endometrial lesions. METHODS: The 140 patients with endometrial lesions who were treated in our hospital from April 2018 to October 2019 were used as the research subjects. All patients underwent transvaginal color ultrasound and transabdominal color ultrasound. We compared the diagnostic coincidence and image display effects of the two different examination methods, and the endometrial thickness, blood flow, uterine effusion and resistance index of different diseases were observed by transvaginal color ultrasound. RESULTS: The diagnostic coincidence rate of all types of diseases of transvaginal color ultrasound was significantly higher than that of transabdominal color ultrasound (P = 0.001, 0.005, 0.001 and 0.001). In addition, the excellent and good rate of image display of transvaginal color ultrasound was higher than that of transabdominal color ultrasound (P = 0.001). There were significant differences in endometrial thickness in patients with different types of endometrial lesions through the transvaginal color examination (P = 0.001). The incidence rate of uterine effusion in patients with endometrial carcinoma was significantly higher than that in patients with other types of endometrial lesions (P = 0.001), and the rate of the blood flow was the highest (P = 0.001). The comparison of blood flow resistance index indicated that the blood flow resistance index in endometrial cancer patients was the lowest, which shows that the difference was statistically significant (P = 0.001). CONCLUSION: The overall diagnostic efficacy of transvaginal color ultrasound in the clinical diagnosis of endometrial lesions is better than that of transabdominal color ultrasound, which held higher diagnostic coincidence rate and image display effect. There were significant differences in the thickness of the endometrium and the blood flow in different types of lesions.

4.
Int Immunopharmacol ; 26(1): 188-93, 2015 May.
Article de Anglais | MEDLINE | ID: mdl-25601497

RÉSUMÉ

BACKGROUND: Baicalin has been shown to possess various pharmacological actions, a recent study revealed that baicalin can attenuate pulmonary hypertension and pulmonary vascular remodeling through the inhibition of pulmonary artery smooth muscle cell proliferation, however, the potential mechanism remains unexplored. In this study, we investigated the therapeutic effect of baicalin on a rat model of monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) and attempted to further clarify the possible mechanisms underlying the anti-inflammatory. METHODS AND RESULTS: Our research showed that compared with MCT-induced PAH model rats, rats administered intragrastically with 100mg/kg baicalin showed the following after two weeks: the right ventricular systolic pressure (RVSP) and the right ventricle/left ventricle plus septum (RV/LV+S) ratio were lower (P<0.05); the intima thickening and luminal stenosis were improved (P<0.05); the mRNA levels of tumor necrosis factor alpha (TNF-α), interleukin-11ß (IL-1ß), IL-6, and endothelin-1 (ET-1) were obviously reduced by quantitative reverse transcription-polymerase chain reaction (qRT-PCR); the protein expression of transforming growth factor-ß1 (TGF-ß1), intercellular cell adhesion molecule-1 (ICAM-1) and nuclear factor-κB (NF-κB) were significantly decreased (P<0.05); and the expression of inhibitor of NF-κB (I-κB) was increased (P<0.05) through immunohistochemical and western blot. CONCLUSION: We studied the protective effects of baicalin against the lung and heart damage in experimental PAH rats; the therapeutic effects maybe through inhibiting vascular endothelial inflammatory response.


Sujet(s)
Anti-inflammatoires/usage thérapeutique , Flavonoïdes/usage thérapeutique , Hypertension pulmonaire/traitement médicamenteux , Monocrotaline/pharmacologie , Artère pulmonaire/effets des médicaments et des substances chimiques , Animaux , Anti-inflammatoires/administration et posologie , Technique de Western , Cytokines/immunologie , Modèles animaux de maladie humaine , Flavonoïdes/administration et posologie , Hypertension pulmonaire/induit chimiquement , Hypertension pulmonaire/immunologie , Hypertension pulmonaire/anatomopathologie , Immunohistochimie , Poumon/vascularisation , Poumon/effets des médicaments et des substances chimiques , Poumon/anatomopathologie , Artère pulmonaire/immunologie , Artère pulmonaire/anatomopathologie , Rat Wistar , Remodelage vasculaire/effets des médicaments et des substances chimiques
5.
Mol Med Rep ; 11(3): 1945-50, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25406024

RÉSUMÉ

The aim of the present study was to investigate the effect of bone marrow­derived mesenchymal stem cells (BMSCs) in the treatment of lung injury in a mouse model of bronchopulmonary dysplasia (BPD) and examine the underlying mechanisms. A mouse model of BPD was created using continuous exposure to high oxygen levels for 14 days. BMSCs were isolated, cultured and then labeled with green fluorescent protein. Cells (1x106) were subsequently injected intravenously 1 h prior to high oxygen treatment. Animals were randomly divided into three groups (n=5 in each): Control group, BPD model group and BMSC injection group. At two weeks post­treatment, the expression of transforming growth factor­ß1 (TGF­ß1), vascular endothelial growth factor (VEGF) and von Willebrand factor (vWF) was detected using immunohistochemical staining and immunofluorescence. Compared with the BPD model group, the body weight, airway structure and levels of TGF­ß1 and VEGF were significantly improved in the BMSC­treated group. Immunofluorescence observations indicated that BMSCs were able to differentiate into cells expressing vWF and VEGF, which are markers of vascular tissues. The present study demonstrated that intravenous injection of BMSCs significantly improved lung damage in a neonatal mouse model of BPD at 14 days following hyperoxia­induced injury. This provides novel information which may be used to guide further investigation into the use of stem cells in BPD.


Sujet(s)
Dysplasie bronchopulmonaire/étiologie , Transplantation de cellules souches mésenchymateuses , Cellules souches mésenchymateuses/cytologie , Cellules souches mésenchymateuses/métabolisme , Animaux , Animaux nouveau-nés , Poids , Dysplasie bronchopulmonaire/métabolisme , Dysplasie bronchopulmonaire/anatomopathologie , Dysplasie bronchopulmonaire/thérapie , Techniques de culture cellulaire , Modèles animaux de maladie humaine , Expression des gènes , Gènes rapporteurs , Souris , ARN messager/génétique , Transfection , Facteur de croissance transformant bêta-1/génétique , Facteur de croissance transformant bêta-1/métabolisme , Facteur de croissance endothéliale vasculaire de type A/génétique , Facteur de croissance endothéliale vasculaire de type A/métabolisme
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE